Clinical Trials Logo
  1. Home
  2. Bipolar II Disorder
  3. NCT06184581

Lithium Versus Lamotrigine in Bipolar Disorder, Type II — LiLa-Bipolar  

Bipolar II Disorder Clinical Trial

Official title:
Lithium Versus Lamotrigine in Bipolar Disorder, Type II - a Single Blinded Randomized Controlled Trial (the LiLa-Bipolar RCT)

Clinical Trial Summary

The investigators want in a 6-month randomized controlled trial (RCT) to compare effects of lithium versus lamotrigine on mood stabilization and other critical patient outcomes in patients with BDII.

Clinical Trial Description

Although BDII is more prevalent and with a higher disease burden, including more and longer depressive episodes and lower functioning, than bipolar disorder, type I (BDI), effects of pharmacological treatment including the most frequently used drugs in clinical practice lithium and lamotrigine, is substantially understudied. The investigators want in a 6-month randomized controlled trial (RCT) to compare effects of lithium versus lamotrigine on mood stabilization and other critical patient outcomes in patients with BDII. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06184581
Study type Interventional
Source Mental Health Services in the Capital Region, Denmark
Contact Lars Vedel Kessing, professor, MD, DMSc.
Phone +45 38 64 70 81
Email lars.vedel.kessing@regionh.dk
Status Recruiting
Phase Phase 4
Start date May 8, 2024
Completion date December 1, 2027
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03641300 - Efficacy of Convulsive Therapies for Bipolar Depression N/A
Recruiting NCT05340686 - Braining- Aerobic Physical Activity as Add on Treatment in Bipolar Depression N/A
Completed NCT00761761 - Sensoril(Ashwaganhda)for Bipolar Disorder Phase 3
Active, not recruiting NCT04561622 - Emotional Proactive Processing in Bipolar Disorder
Completed NCT03334721 - Gabapentin for Bipolar & Cannabis Use Disorders Phase 2
Active, not recruiting NCT05658510 - Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III) Phase 3
Active, not recruiting NCT03484494 - Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression N/A
Recruiting NCT05400785 - Efficacy of the Mobile Application for Prediction and Prevention of Mood Episode Recurrence Based on Machine Learning N/A
Completed NCT05340504 - Evaluating the Hypothesized Mechanism of Action of N-acetylcysteine for Bipolar Disorder Phase 2
Active, not recruiting NCT05249309 - Naturalistic Study of Ketamine in the Treatment of Depression
Recruiting NCT04211428 - A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Bipolar Disorder
Completed NCT03822416 - Treating Smokers With Mental Illness Phase 2
Completed NCT01588457 - Sequential Multiple Assignment Treatment for Bipolar Disorder Phase 4
Completed NCT03156504 - The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression. Phase 4
Recruiting NCT05004896 - Ketamine for Treatment-Resistant Bipolar Disorder Phase 2
Terminated NCT02491307 - Ginger.io Behavioral Health Study N/A
Recruiting NCT05427123 - Children's Bipolar Network Treatment Trial I
Not yet recruiting NCT05705063 - Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar Illness N/A
Recruiting NCT05065294 - Psilocybin Therapy for Depression in Bipolar II Disorder Phase 2
Completed NCT02593643 - Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression. Early Phase 1